Olivia B.O.B.ParksOlivia B.O.B. i inni, Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease, „Frontiers in Cell and Developmental Biology”, 3, 2016, DOI: 10.3389/fcell.2015.00085, ISSN2296-634X, PMID: 26793707, PMCID: PMC4710696 [dostęp 2021-03-18](ang.).
Ming-HongM.H.XieMing-HongM.H. i inni, Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2–4 and IL-22R, „Journal of Biological Chemistry”, 275 (40), 2000, s. 31335–31339, DOI: 10.1074/jbc.M005304200, PMID: 10875937 [dostęp 2021-03-18](ang.).
KerstinK.WolkKerstinK. i inni, IL-22 Increases the Innate Immunity of Tissues, „Immunity”, 21 (2), 2004, s. 241–254, DOI: 10.1016/j.immuni.2004.07.007, PMID: 15308104 [dostęp 2021-03-18](ang.).
RobertR.SabatRobertR., WenjunW.OuyangWenjunW., KerstinK.WolkKerstinK., Therapeutic opportunities of the IL-22-IL-22R1 system, „Nature Reviews Drug Discovery”, 13 (1), 2014, s. 21–38, DOI: 10.1038/nrd4176, ISSN1474-1776, PMID: 24378801(ang.). 1 stycznia
Shean J.S.J.AujlaShean J.S.J. i inni, IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia, „Nature Medicine”, 14 (3), 2008, s. 275–281, DOI: 10.1038/nm1710, ISSN1078-8956, PMID: 18264110, PMCID: PMC2901867(ang.).
IlonaI.KryczekIlonaI. i inni, IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L, „Immunity”, 40 (5), s. 772–784, DOI: 10.1016/j.immuni.2014.03.010, PMID: 24816405, PMCID: PMC4032366.
nih.gov
ncbi.nlm.nih.gov
Olivia B.O.B.ParksOlivia B.O.B. i inni, Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease, „Frontiers in Cell and Developmental Biology”, 3, 2016, DOI: 10.3389/fcell.2015.00085, ISSN2296-634X, PMID: 26793707, PMCID: PMC4710696 [dostęp 2021-03-18](ang.).
Ming-HongM.H.XieMing-HongM.H. i inni, Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2–4 and IL-22R, „Journal of Biological Chemistry”, 275 (40), 2000, s. 31335–31339, DOI: 10.1074/jbc.M005304200, PMID: 10875937 [dostęp 2021-03-18](ang.).
KerstinK.WolkKerstinK. i inni, IL-22 Increases the Innate Immunity of Tissues, „Immunity”, 21 (2), 2004, s. 241–254, DOI: 10.1016/j.immuni.2004.07.007, PMID: 15308104 [dostęp 2021-03-18](ang.).
RobertR.SabatRobertR., WenjunW.OuyangWenjunW., KerstinK.WolkKerstinK., Therapeutic opportunities of the IL-22-IL-22R1 system, „Nature Reviews Drug Discovery”, 13 (1), 2014, s. 21–38, DOI: 10.1038/nrd4176, ISSN1474-1776, PMID: 24378801(ang.). 1 stycznia
Shean J.S.J.AujlaShean J.S.J. i inni, IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia, „Nature Medicine”, 14 (3), 2008, s. 275–281, DOI: 10.1038/nm1710, ISSN1078-8956, PMID: 18264110, PMCID: PMC2901867(ang.).
IlonaI.KryczekIlonaI. i inni, IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L, „Immunity”, 40 (5), s. 772–784, DOI: 10.1016/j.immuni.2014.03.010, PMID: 24816405, PMCID: PMC4032366.
worldcat.org
Olivia B.O.B.ParksOlivia B.O.B. i inni, Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease, „Frontiers in Cell and Developmental Biology”, 3, 2016, DOI: 10.3389/fcell.2015.00085, ISSN2296-634X, PMID: 26793707, PMCID: PMC4710696 [dostęp 2021-03-18](ang.).
RobertR.SabatRobertR., WenjunW.OuyangWenjunW., KerstinK.WolkKerstinK., Therapeutic opportunities of the IL-22-IL-22R1 system, „Nature Reviews Drug Discovery”, 13 (1), 2014, s. 21–38, DOI: 10.1038/nrd4176, ISSN1474-1776, PMID: 24378801(ang.). 1 stycznia
Shean J.S.J.AujlaShean J.S.J. i inni, IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia, „Nature Medicine”, 14 (3), 2008, s. 275–281, DOI: 10.1038/nm1710, ISSN1078-8956, PMID: 18264110, PMCID: PMC2901867(ang.).